Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer.
Because of encouraging results when human leukocyte interferon was given for 5 to 7 days to treat early localized herpes zoster in patients with cancer, a small placebo-controlled, randomized, double-blind trial was set up involving only 48 h of therapy. In this trial, there was no effect on acute p...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1981
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181382/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6166245/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.19.1.193 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|